Aegerion Pharmaceuticals | Evaluate

October 04, 2016

Debt binge sees Aralez become a mini-Valeant

Genmab and Tesaro lead first-half gainers as Endo and Infinity falter

June 16, 2016

QLT and Aegerion put each other out of their miseries

November 24, 2015

Astra gives as well as taking away

January 08, 2015

Buoyant small pharma market hides some big losers

November 12, 2014

Debt-funded biotechs under the spotlight

November 06, 2014

An expensive distraction strategy for Aegerion

July 03, 2014

Market wobble fails to derail mid and small-caps

February 27, 2014

Lack of talk – for once – sees Aegerion’s shares fall

November 07, 2013

Small companies’ struggles sound a warning over in-house drug launches

April 25, 2013

Calling the top? Ever-rising valuations spark biotech worries

Load More